Buku Medicine is a free app for any clinicians who refer to specialist doctors. It aims to reduce or improve referrals by providing information about the most common referrals in the most convenient way. This helps referrers, recipients and patients. It is for all grades of generalist and specialist doctors, specialist nurses, physician assistants and has links to key references and guidelines. (See disclaimer below for information about appropriate use of this app).
'Buku' is the Chichewa word for book or reference. Chichewa is spoken in Malawi where the pathology project MPathE (where Professor O’Brien has helped) is running.
Data collected from users shows that it can prevent a call to haematology completely for 21% of clinical queries, and start further investigations to expedite care for up to 60% more. This reduces the on-call burden on haematologists and improves patient care by improving clinician efficiency. See our website for testimonials of how it has helped users.
Our achievements so far;
The information included is concise to make it easy to use, and further reading should be undertaken to gain a full understanding of the topics covered.
Common causes are listed by frequency from general medical literature and our clinical experience.
Disclaimer: This app has been prepared by Buku Tech Limited to provide guidance and assistance to healthcare practitioners but does not constitute medical advice. Its content is general in nature, may not reflect all recent clinical developments and guidelines and may not apply to the specific facts or circumstances of a particular case and should therefore be used in conjunction with clinical judgement and local medical specialist advice if required. While this app does provide accurate and useful information, Buku Tech Limited makes no warranty, express or implied, with regard to the accuracy, omissions and usefulness of the information the app contains. Buku Tech Limited does not accept any responsibility in contract, tort (including negligence), breach of statutory duty or otherwise arising under or connection with this note for (i) use of this app or (ii) any action taken as a result of the information provided in it or (iii) subsequent damages resulting from the use of the information provided. Nothing in this disclaimer notice limits any liability which cannot legally be limited.
Follow us on Twitter on @bukumedicine, @bukuhaematology, @bukurenal and @bukuendo
For those with an interest in haematology follow @teamhaem on twitter for clinical cases and educational resources.
Governance - Our content is written by registrars in their respective fields. Per specialty, there are 2-3 registrars to write content, and a consultant to review that content. This is monitored through a database of active modules, with review dates set for each module. Modules are reviewed every 6 months. Content is general information as would be expected knowledge of a registrar in the specialty. No content is taken into the App from patients, and therefore Buku Medicine is not a medical device as per the MHRA definition.
© Buku Tech Limited 2023
All rights reserved. Not to be reproduced in whole or in part without the permission of the copyright owner.
@bukuhaematology, @bukurenal, @bukuendo
We have now deactivated this version of Buku Medicine. We now have a new (but still free!) version available from AppStores - this should happen for most users as an automatic update but you may need to go into the Google Play Store app/Apple App Store app to activate the update.
We are sorry but there is a technical issue at present where the Android App will not automatically update - we have contacted Google Play about this. In the meantime, if you would like the new version, please uninstall and re-install of the App. Apologies for this issue.
The Buku Medicine team
Taken from our blog Buku Medicine Version 2 — Buku Medicine
Buku Medicine has been running for 6 years now as an entirely voluntary platform to improve clinician workload and patient care. It is run by a team of 4 clinicians supported by excellent content contributors. We now have over 35,000 active users in the UK and abroad and this has put a burden on our current app platform.
In order to continue our work, we have had a new version of the App developed to cope with this workload and also offer us a means of sustainability. We will shortly be releasing this new (but still free!) version of the App which will continue to offer all of the same content you have had up to now, and soon will also be offering palliative care and neurology content. There will also be a search function which has been requested by many of our users.
Alongside this, we will be offering additional educational material which will be available behind a low cost annual subscription. This will cover different topics within our specialities, initially haematology only, and covers more about the conditions than the tests. It will help users understand the difference between a CLL and a CML for example, and key points about how these patients are cared for and disease trajectories. This will be offered as brief and standard written modules (the brief can be read in a minute or two for a brief intro or quick reminder of the topic), pictorial and video content. We have prepared almost 30 written modules, almost 40 videos and pictorial content for many of these with more to come. Users can also reflect on this content and generate a PDF of their reflections to submit to portfolios.
We will offer this content for the following subscription costs;
£4.99 per year
£7.99 for 2 years (restricted to the first 1500 subscribers)
£11.99 for 2 years subscription but also giving an additional contribution to support our work
Our aim is to cover our costs, and continue to improve the App, offering the best possible service to the NHS and resource-poor healthcare environments. App development has been a significant cost, some of which our team are covering themselves at present. Your subscription (only 1.5 coffees per year!) will allow you access to the new educational content, and any further content to come in haematology and other specialties, but also allow us to maintain the free core content which has already had such a positive significant impact on referrals to specialties already.
Thank you for your ongoing support,
Alex, Steve, Kerri and Toby
If you are a haematologist and interested in taking part in a pilot of new customisable content adapted to local practice, please get in touch with us at email@example.com.